Systemic IL-2/anti-IL-2Ab complex combined with sublingual immunotherapy suppresses experimental food allergy in mice through induction of mucosal regulatory T cells-Reference-Cited by-同舟云学术

Systemic IL-2/anti-IL-2Ab complex combined with sublingual immunotherapy suppresses experimental food allergy in mice through induction of mucosal regulatory T cells

Published:2018-04 Issue:4 Volume:73 Page:885-895
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Smaldini P. L.¹,Trejo F.¹,Cohen J. L.²³⁴,Piaggio E.⁵⁶,Docena G. H.¹^ORCID

Affiliation:

1. Instituto de Estudios Inmunológicos y Fisiopatológicos (IIFP); CONICET y Universidad Nacional de La Plata; La Plata Argentina

2. Université Paris-Est; UMR_S955; UPEC; Créteil France

3. Inserm, U955; Equipe 21; Créteil France

4. Hôpital Henri Mondor; UPEC; APHP; Inserm; CIC Biothérapie; Créteil France

5. Institut Curie; PSL Research University; INSERM U932; Translational Immunotherapy team; Paris France

6. Institut Curie; Centre d'Investigation Clinique Biothérapie CICBT 1428; Paris France

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/all.13402/fullpdf

Reference45 articles.

1. Food allergy: riding the second wave of the allergy epidemic;Prescott;Pediatr Allergy Immunol,2011

2. 2015 update of the evidence base : world Allergy Organization anaphylaxis guidelines;Simons;World Allergy Organ J,2015

3. Characterization of the allergic T-cell response to Pru p 3, the nonspecific lipid transfer protein in peach;Schulten;J Allergy Clin Immunol,2009

4. T cell responses to major peanut allergens in children with and without peanut allergy;Flinterman;Clin Exp Allergy,2010

5. Fatal anaphylaxis: mortality rate and risk Factors;Turner;J Allergy Clin Immunol Pract,2017

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low-dose interleukin-2 in birch pollen allergy: a phase-2 randomized double-blind placebo-controlled trial;2024-09-04

2. A Preliminary Investigation of the Differences in Immune Responses in Different Strains of Mice with Localized Allergic Rhinitis Tolerance Models;2024-04-24

3. A CD25-biased interleukin-2 for autoimmune therapy engineered via a semi-synthetic organism;Communications Medicine;2024-03-26

4. Immunoswitch Nanomodulators Enable Active Targeting and Selective Proliferation of Regulatory T Cells for Multiple Sclerosis Therapy;ACS Nano;2023-12-19

5. The T-Cell Growth Factor Interleukin-2, Which Is Occasionally Targeted by Autoantibodies, Qualifies as Drug for the Treatment of Allergy, Autoimmunity, and Cancer: Collegium Internationale Allergologicum (CIA) Update 2024;International Archives of Allergy and Immunology;2023-12-12